Cargando…

Factors affecting adherence to non-pharmaceutical interventions for COVID-19 infections in the first year of the pandemic in the UK

OBJECTIVE: Non-pharmaceutical interventions (NPIs), including wearing face covering/masks, social distancing and working from home, have been introduced to control SARS-CoV-2 infections. We provide individual-level empirical evidence of whether adherence reduces infections. SETTING AND PARTICIPANTS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Xuejie, Brazel, David M, Mills, Melinda C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557247/ https://www.ncbi.nlm.nih.gov/pubmed/34697126 http://dx.doi.org/10.1136/bmjopen-2021-054200

Ejemplares similares

Gender differences in sleep disruption during COVID-19: cross-sectional analyses from two UK nationally representative surveys
por: Ding, Xuejie, et al.
Publicado: (2022)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Estimating the effect of non-pharmaceutical interventions on US SARS-CoV-2 infections in the first year of the pandemic
por: Duncan, N. A., et al.
Publicado: (2022)

Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
por: Rickard, Emily, et al.
Publicado: (2023)

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020)

Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020
por: Polak, Tobias B, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on routine vaccination services in Shaanxi province, Northwest China: Non-pharmaceutical intervention period and mass COVID-19 vaccination period
por: Zhang, Chao, et al.
Publicado: (2023)

What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
por: Bugge, Christoffer, et al.
Publicado: (2021)

Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
por: Ma, Junxiong, et al.
Publicado: (2022)

Foundation Year 2 doctors’ reasons for leaving UK medicine: an in-depth analysis of decision-making using semistructured interviews
por: Smith, Samantha E, et al.
Publicado: (2018)

Public acceptability of non-pharmaceutical interventions to control a pandemic in the UK: a discrete choice experiment
por: Loría-Rebolledo, Luis Enrique, et al.
Publicado: (2022)

Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
por: Parker, Lisa, et al.
Publicado: (2019)

Gender and racialisation of pharmaceutical sector leaders in Canada: a cross-sectional study
por: Satgunanathan, Kasthuri, et al.
Publicado: (2023)

The changing health needs of the UK population
por: McKee, Martin, et al.
Publicado: (2021)

Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance
por: Milliken, Debbie, et al.
Publicado: (2015)

Exploring reasons behind UK doctors leaving the medical profession: a series of qualitative interviews with former UK doctors
por: Pathmanathan, Arin, et al.
Publicado: (2023)

National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study
por: Lexchin, Joel, et al.
Publicado: (2022)

Factors influencing the decisions of senior UK doctors to retire or remain in medicine: national surveys of the UK-trained medical graduates of 1974 and 1977
por: Smith, Fay, et al.
Publicado: (2017)

Effect of ‘lifestyle stigma’ on public support for NHS-provisioned pre-exposure prophylaxis (PrEP) and preventative interventions for HPV and type 2 diabetes: a nationwide UK survey
por: Hildebrandt, Timothy, et al.
Publicado: (2019)

What is the right level of spending needed for health and care in the UK?
por: Charlesworth, Anita, et al.
Publicado: (2021)

Gene-x-environment analysis supports protective effects of eveningness chronotype on self-reported and actigraphy-derived sleep duration among those who always work night shifts in the UK Biobank
por: Akimova, Evelina T, et al.
Publicado: (2023)

Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
por: Stoll, Marlene, et al.
Publicado: (2020)

E-cigarette marketing in UK stores: an observational audit and retailers’ views
por: Eadie, D, et al.
Publicado: (2015)

Securing a sustainable and fit-for-purpose UK health and care workforce
por: Anderson, Michael, et al.
Publicado: (2021)

Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
por: Moynihan, Ray, et al.
Publicado: (2019)

Regional and temporal variations in organ donation across the UK (secondary analyses of databases)
por: McGlade, Donal, et al.
Publicado: (2011)

A systematic analysis of UK cancer research funding by gender of primary investigator
por: Zhou, Charlie D, et al.
Publicado: (2018)

Applying crisis standards of care to critically ill patients during the COVID‐19 pandemic: Does race/ethnicity affect triage scoring?
por: Molina, Melanie F., et al.
Publicado: (2021)

Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review
por: Fickweiler, Freek, et al.
Publicado: (2017)

Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
por: Stoll, Marlene, et al.
Publicado: (2022)

A qualitative study of manufacturers' submissions to the UK NICE single technology appraisal process
por: Kaltenthaler, Eva C, et al.
Publicado: (2012)

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013)

Characterising the evidence base for advanced clinical practice in the UK: a scoping review protocol
por: Evans, Catrin, et al.
Publicado: (2020)

Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts
por: Heneghan, C, et al.
Publicado: (2011)

Hospital bed capacity and usage across secondary healthcare providers in England during the first wave of the COVID-19 pandemic: a descriptive analysis
por: Mateen, Bilal Akhter, et al.
Publicado: (2021)

NHS ‘Learning from Deaths’ reports: a qualitative and quantitative document analysis of the first year of a countrywide patient safety programme
por: Brummell, Zoe, et al.
Publicado: (2021)

Delayed emergencies: The composition and magnitude of non‐respiratory emergency department visits during the COVID‐19 pandemic
por: Friedman, Ari B., et al.
Publicado: (2021)

Doctors' experiences and their perception of the most stressful aspects of complaints processes in the UK: an analysis of qualitative survey data
por: Bourne, Tom, et al.
Publicado: (2016)

Characterising the outcomes, impacts and implementation challenges of advanced clinical practice roles in the UK: a scoping review
por: Evans, Catrin, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the conduct of non-COVID-19 clinical trials: protocol for a scoping review
por: Shang, Wenru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f68inpknd19bdafp1043779e0k